Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Daily News

Symplicity Spyral Approved: FDA Clears Second Renal Denervation System

Todd Neale

November 20, 2023

News Daily News

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

Michael O'Riordan

September 29, 2023

News Daily News

European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba

Michael O'Riordan

September 15, 2023

News Daily News

Mortality, CVD Benefits Seen at Relatively Low Daily Step Counts

Michael O'Riordan

September 08, 2023

News Daily News

AHA, AMA Make Call for Enhanced Efforts to Control Americans’ BP

Todd Neale

September 07, 2023

News Daily News

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

L.A. McKeown

August 23, 2023

News Daily News

CVD Risk Reduction With Exercise Also Seen in ‘Weekend Warriors’

Michael O'Riordan

July 24, 2023

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

News Daily News

CVD Risks After Pregnancy Linked to Prenatal Depression

L.A. McKeown

April 21, 2023

News Daily News

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

L.A. McKeown

April 19, 2023

News Daily News

Inactivity Pandemic Poised to Undo CVD Prevention Advances

Michael O'Riordan

April 11, 2023

News Opinion CV Team Dispatch

April 2023 News Roundup

L.A. McKeown

April 01, 2023

News Daily News

Regaining Weight Won’t Erode CV Risk Factor Benefits Short Term

L.A. McKeown

March 31, 2023

News Daily News

Longer and Greater Risk Factor Exposure, More CVD

Caitlin E. Cox

March 23, 2023

News Conference News ACC 2023

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

Michael O'Riordan

March 14, 2023

News Daily News

More Frequent, Longer Movement Breaks Can Attenuate Harms of Sitting

Yael L. Maxwell

January 13, 2023

Advertisement

Symplicity Spyral Approved: FDA Clears Second Renal Denervation System

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba

Mortality, CVD Benefits Seen at Relatively Low Daily Step Counts

AHA, AMA Make Call for Enhanced Efforts to Control Americans’ BP

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

CVD Risk Reduction With Exercise Also Seen in ‘Weekend Warriors’

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

CVD Risks After Pregnancy Linked to Prenatal Depression

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

Inactivity Pandemic Poised to Undo CVD Prevention Advances

April 2023 News Roundup

Regaining Weight Won’t Erode CV Risk Factor Benefits Short Term

Longer and Greater Risk Factor Exposure, More CVD

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

More Frequent, Longer Movement Breaks Can Attenuate Harms of Sitting

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content